Ph.D., CEO, Presagen & Life Whisperer
Biography
Dr Michelle Perugini is an academic, entrepreneur, and an internationally renowned expert in digital health, medical research, and advanced AI technologies. Dr Perugini has a PhD in Medicine and was a stem cell biologist for a decade. Michelle was also the founder of the global technology company ISD Analytics, leading the commercialisation of its award-winning predictive analytics product Simulait, ISD was acquired by Ernst and Young {EY) in 2015. Dr Perugini is now the Co-Founder and CEO of Presagen, an AI company that connects clinics globally to build scalable AI medical products. Presagen co-creates scalable AI products with clinics while preserving data privacy and sharing the commercial value. Presagen’s first product is Life Whisperer that uses AI to assist clinicians to select viable embryos in IVF to improve outcomes for couples wanting to have children. International clinical studies have shown that Life Whisperer is 30% more accurate than visual selection of embryos by skilled embryologists.
Session Abstract – PMWC 2020 Silicon Valley
Track 6 - January 22 2.30 P.M.-3.45 P.M.,Track 7 - January 23 1.15 P.M.-1.30 P.M.,Track 6 - January 24 9.00 A.M.-1.15 P.M.
The PMWC 2020 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
